Article Per Year (5 Year)
p-Index From 2019 - 2024
0.23
P-Index
This Author published in this journals
All Journal Journal of Pharmaceutical and Sciences.
Ariesta Kirana Efmisa
Universitas Andalas, Padang, Sumatera Barat, Indonesia.
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Penggunaan Obat Berpotensi Hepatotoksik Pada Pasien Sirosis Hati: Suatu Telaahan Ariesta Kirana Efmisa; Armenia Armenia; Dedy Almasdy
Journal of Pharmaceutical and Sciences JPS Volume 6 Nomor 2 (2023)
Publisher : Fakultas Farmasi Universitas Tjut Nyak Dhien

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (248.144 KB) | DOI: 10.36490/journal-jps.com.v6i2.137

Abstract

Liver cirrhosis is a pathological liver disease characterized by the formation of scar tissue and regenerative nodules in liver cells. This condition leads to changes in the shape and size of the liver, accompanied by increased pressure in the veins and reduced blood flow in the portal vein. Liver cirrhosis is the seventh leading cause of death. Drugs are the main cause of liver damage. More than 900 drugs, toxins and herbs are reported to cause liver damage. The purpose of this review article is to summarize the results of previous studies on the use of hepatotoxic drugs in patients with liver cirrhosis. Data sources for this study were identified through searching Google Scholar, PubMed and Science Direct using the keywords "hepatotoxic drugs" and "liver cirrhosis" in articles published between 2011-2022. Finally, 10 articles were obtained and analyzed. The results of this review article show that liver cirrhosis patients are still often prescribed potentially hepatotoxic drugs. Some commonly prescribed drugs include paracetamol, omeprazol, ranitidine, ceftriaxon, ciprofloxacin, atorvasatin, metformin, and amiodarone.
Co-Authors Armenia, Armenia Dedy Almasdy